Okinawa / Osaka / Dalian / Tokyo / Kyoto / Seoul / Beijing / Mountain View / /
Company
Takara Bio Group / BIO INC. / Name Location Takara Biotechnology (Dalian) Co. Ltd. / AgriBio Takara Bio Farming Center Inc. / Takara Bio Europe S.A.S. / Authorized / Takara Biotechnology (Dalian) Co. Ltd. / Japan Transfer Agent Office Mizuho Trust / MolMed S.p.A. / Takara Holdings Inc. / Takara Korea Biomedical Inc. / Takara Shuzo Co. Ltd. / Clontech Laboratories Inc. / Issued Capital / KINOKO CENTER KIN INC. / Investor Information Takara Bio Inc. / Registrar Mizuho Trust & Banking Co. Ltd. / Takara Bio USA Holdings Inc. / Merging Clontech Laboratories / Trade Name Takara Bio Inc. / /
Continent
Asia / /
Country
Italy / Japan / United States / China / /
Currency
USD / / EUR / /
Event
Dividend Issuance / M&A / Business Partnership / FDA Phase / General or Shareholder Meeting / Company Expansion / /
Facility
National Cancer Center Hospital / Kagoshima University / Mie University / Keio University / HIV University of Pennsylvania / National Cancer Center / National Institute of Biomedical Innovation RetroNectin / Tianjin Cancer Institute / Kyoto Prefectural University of Medicine / Sun Yat-Sen University Medical University / Tianjin Medical University / Iseikai Hyakumanben Clinic / University of Pennsylvania / Kyoto Prefectural University of Medicine Scheduled / /
IndustryTerm
medical technologies / biotechnology tion / biotechnology / health food ingredients / supply products / health food products / cell culture media / technology development / therapies for cancer / mushroom products / pharmaceutical / gene therapy technologies / spectrometry systems / product manufacturing / manufacturing bases / contract services / contract research services / manufacturing base / biotechnology research activities / customers food materials / /
MedicalCondition
HIV / hematological malignancies / relapsed leukemia / T cell therapy ovarian cancer / Cerebral tumors / Esophageal cancer / comprehensive cancer / Hematological tumors / cancer / wtMA24 Esophageal cancer / disease / gene therapy targeting esophageal cancer / AIDS / colorectal cancer MazF / /
MedicalTreatment
immunotherapy / gene therapy / cell therapy / /
Organization
Mie University / University of Pennsylvania / National Institute of Biomedical Innovation RetroNectin / Kyoto Prefectural University of Medicine / the University of Pennsylvania / National Cancer Center of Japan of HSV-TK / Tianjin Medical University / Tianjin Cancer Institute / University of Medicine Scheduled / National Cancer Center in Japan / Japan’s New Energy and Industrial Technology Development Organization / Kagoshima University / New Energy and Industrial Technology Development Organization / Keio University / Mie University School of Medicine / Japanese government / National Cancer Center Hospital / /
Person
Gene Therapies / / /
Position
President / Head Office / Location Head / Major / President & CEO / /
Annual ReportTHE BIOTECHNOLOGY COMPANY TM